This company has been marked as potentially delisted and may not be actively trading. NASDAQ:VTL Vital Therapies (VTL) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisCompetitorsTrendsBuy This Stock About Vital Therapies Stock (NASDAQ:VTL) 30 days 90 days 365 days Advanced Chart Get Vital Therapies alerts:Sign Up Key Stats Today's Range$0.68▼$0.7350-Day Range$0.83▼$14.5052-Week Range$0.15▼$9.75Volume1.22 million shsAverage Volume21.62 million shsMarket Capitalization$30.95 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewImmunic, Inc. develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA.Read More… Receive VTL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vital Therapies and its competitors with MarketBeat's FREE daily newsletter. Email Address VTL Stock News Headlines18,000 vulnerable children could lose ‘vital’ therapy as adoption fund faces axeMarch 31, 2025 | msn.comVeterans Deserve Access To Life-Changing Psychedelics Therapy: A Vital Solution For PTSD And HealingNovember 11, 2024 | benzinga.comYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.June 4, 2025 | Priority Gold (Ad)Lighthouse Center for Vital Living celebrates new buildingOctober 30, 2024 | duluthnewstribune.comVital Care Receives Strategic Investment From Berkshire Partners, Leonard Green & Partners, and Linden Capital PartnersAugust 1, 2024 | tmcnet.comVeterans lobbied for psychedelic therapy, but it may not be enough to save MDMA drug applicationJuly 26, 2024 | msn.comVardhman Textiles Ltd.May 22, 2024 | wsj.comVital Spa celebrates a year on Bridge StreetApril 28, 2024 | yahoo.comSee More Headlines VTL Stock Analysis - Frequently Asked Questions How were Vital Therapies' earnings last quarter? Vital Therapies, Inc. (NASDAQ:VTL) issued its quarterly earnings results on Tuesday, August, 7th. The company reported ($0.30) earnings per share for the quarter, topping analysts' consensus estimates of ($0.33) by $0.03. What other stocks do shareholders of Vital Therapies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Vital Therapies investors own include Xtrackers California Municipal Bond ETF (CA), BlackRock (BLK), Endologix (ELGX), Anthera Pharmaceuticals (ANTH), Bristol-Myers Squibb (BMY), Novavax (NVAX) and Viking Therapeutics (VKTX). Company Calendar Last Earnings8/07/2018Today6/04/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:VTL CIK1280776 Webvitaltherapies.com Phone(858) 673-6840FaxN/AEmployees10Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$41.47 million Net MarginsN/A Pretax MarginN/A Return on Equity-235.33% Return on Assets-182.35% Debt Debt-to-Equity RatioN/A Current Ratio6.97 Quick Ratio6.97 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.29 per share Price / Book2.52Miscellaneous Outstanding Shares42,370,000Free FloatN/AMarket Cap$30.95 million OptionableNot Optionable Beta3.51 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (NASDAQ:VTL) was last updated on 6/4/2025 by MarketBeat.com Staff From Our PartnersThe Real Reason Silver Prices Are SoaringElon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredFPV Drone Innovator Secures Major Defense ContractIn May, Ukraine launched Operation Spider Web - a 117-drone FPV swarm that devastated Russian fuel depots and ...The Tomorrow Investor | SponsoredJunior Explorer Taps Into TSMC’s $165 Billion Chip CorridorThe chip war is moving underground. As the U.S. ramps up semiconductor production to outpace China, an unex...Capital Trends | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe Recession Already Started, Are You Prepared?Global central banks are stockpiling gold. Billionaires are hedging with precious metals. And thousands of Ame...Lear Capital | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vital Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vital Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VTL Stock Free VTL Stock Alerts